Together we will beat cancer

Donate

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

Read More

Opinion: ‘The idea that a tobacco company might profit off my disease appals me’

Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International’s bid for pharmaceutical company Vectura.

Read More

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

Read More

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

Read More

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

Read More

England: Smoking responsible for twice as many cancers in most deprived groups

Over 11,000 cases of cancer were linked to smoking in the lowest income group, compared to around 6,000 in the highest.

Read More

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

Read More

Turning the Life Sciences Vision into reality

The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK’s CEO, Michelle Mitchell, knows that it requires real investment.

Read More

American tobacco company offers £1bn for UK pharma firm Vectura

Philip Morris International (PMI), the American tobacco company, and maker of Marlboro cigarettes, is buying Vectura, the British respiratory drugs company.

Read More

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Read More